Nuclear magnetic resonance-based lipid metabolite profiles for differentiation of patients with liver cirrhosis with and without hepatocellular carcinoma
Nuclear magnetic resonance based assessment of lipidomic and metabolomic profiles permit the differentiation of cancer from liver cirrhosis. The data obtained suggests a possible role of lipidomic based serum profiles for early detection.
Authors
- Sabine Weber (ORCID: https://orcid.org/0000-0001-7077-8078)
- Julia V. Mayerle (ORCID: https://orcid.org/0000-0002-3666-6459)
- Peter Malfertheiner (ORCID: https://orcid.org/0000-0001-8439-9036)
- Regina Schinner (ORCID: https://orcid.org/0000-0002-3082-6570)
- Jens Ricke (ORCID: https://orcid.org/0000-0001-8762-8594)
- Marianna Alunni‐Fabbroni (ORCID: https://orcid.org/0000-0002-9710-1662)
- Eric Schiffer
- L Nardone (ORCID: https://orcid.org/0009-0004-2783-3288)
- Max Seidensticker (ORCID: https://orcid.org/0000-0002-2481-5410)
- Sebastian de Jel
Institutions
- LMU Klinikum (DE)
- University of Regensburg (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2025-04-04
- DOI
- https://doi.org/10.1007/s00432-025-06178-x
- Citations
- 1
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Ludwig-Maximilians-Universität München